Litcius/Paper detail

Non-secretory multiple myeloma: Diagnosis and management

Grzegorz Charliński, Artur Jurczyszyn

2021Advances in Clinical and Experimental Medicine24 citationsDOIOpen Access PDF

Abstract

Multiple myeloma (MM) is one of the most commonly diagnosed blood cancers. One criterion for the diagnosis of MM is serum and/or urine monoclonal protein produced by clonal plasmocytes. However, about 1-2% of MM cases do not have monoclonal protein. If other diagnostic criteria are present, the possibility of a diagnosis of non-secretory MM should be considered. As the different types of non-secretory MM depend on the underlying cause, the current definition is considered insufficient. Currently, both the diagnosis and treatment of non-secretory MM are the same as those of secretory MM. Due to the rarity of non-secretory MM, most findings are from retrospective studies on small groups of patients and case reports. The method of monitoring the effectiveness of MM treatment remains a problem, as it is usually based on the assessment of the percentage of clonal plasma cells in the bone marrow and imaging studies.

Topics & Concepts

Multiple myelomaSecretory proteinMonoclonalMedicineUrineBone marrowMonoclonal antibodyRetrospective cohort studyPathologyInternal medicineRadiologySecretionImmunologyAntibodyMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and Analysis
Non-secretory multiple myeloma: Diagnosis and management | Litcius